Health Special: Lupus and Plasminogen Deficiency
November 6, 2017
Treatment and Trials for Lupus and Plasminogen Deficiency.
This episode of The Balancing Act focuses on two very different diseases: Lupus and Plasminogen Deficiency (PLGD). Fortunately, research is yielding encouraging treatment options for both diseases.
The Lupus Foundation of America estimates that 1.5 million Americans — and at least five million people worldwide — have a form of lupus. Join us for a discussion of lupus and lupus nephritis, meet two courageous women who are battling the disease, plus we examine the latest clinical trials giving hope to medical professionals and sufferers.
Then, in our recurring Behind the Mystery segment, we examine Plasminogen Deficiency (PLGD) or Hypoplasminogenemia, an ultra-rare disease often misdiagnosed. A systemic and potentially life-threatening disease, PLGD frequently presents with ligneous conjunctivitis, an eye condition where the lids develop membranous growths. We meet a young lady who has been dealing with PLGD almost since birth, along with her mother, who has become a vocal advocate.
Behind the Mystery is a special segment dedicated to revolutionizing the way the health care system works for those suffering from a rare and genetic disorder.
Behind the Mystery takes a closer look at one of the two types of Polycystic Kidney disease. Autosomal Dominant Polycystic Kidney Disease, or ADPKD, is a rare, genetic condition.
Behind the Mystery takes a closer look at Blastic Plasmacytoid Dendritic Cell Neoplasm, a rare disease that is often misdiagnosed and affects at least 500 to 1,000 patients each year in the U.S.